<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 67-kDa laminin receptor (67LR) is a laminin-binding protein overexpressed in various types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, including bile duct <z:mp ids='MP_0002038'>carcinoma</z:mp>, colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e>, and <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>67LR plays a vital role in growth and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and resistance to chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show that 67LR functions as a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific <z:hpo ids='HP_0011420'>death</z:hpo> receptor </plain></SENT>
<SENT sid="3" pm="."><plain>In this cell <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway, cGMP initiated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific cell <z:hpo ids='HP_0011420'>death</z:hpo> by activating the PKCδ/acid sphingomyelinase (PKCδ/ASM) pathway </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, upregulation of cGMP was a rate-determining process of 67LR-dependent cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by the green tea <z:chebi fb="0" ids="26195">polyphenol</z:chebi> <z:chebi fb="0" ids="42255">(-)-epigallocatechin</z:chebi>-3-O-<z:chebi fb="0" ids="16918">gallate</z:chebi> (<z:chebi fb="0" ids="4806">EGCG</z:chebi>), a natural ligand of 67LR </plain></SENT>
<SENT sid="5" pm="."><plain>We found that phosphodiesterase 5 (PDE5), a negative regulator of cGMP, was abnormally expressed in <z:e sem="disease" ids="C0346429" disease_type="Neoplastic Process" abbrv="">multiple cancers</z:e> and attenuated 67LR-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Vardenafil, a PDE5 inhibitor that is used to treat <z:hpo ids='HP_0000802'>erectile dysfunction</z:hpo>, significantly potentiated the <z:chebi fb="0" ids="4806">EGCG</z:chebi>-activated 67LR-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> without affecting <z:mpath ids='MPATH_458'>normal</z:mpath> cells and prolonged the survival time in a mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that PDE5 inhibitors could be used to elevate cGMP levels to induce 67LR-mediated, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>